CARGO Therapeutics (CRGX)

Profile

Full Name

CARGO Therapeutics, Inc.

Ticker Symbol

CRGX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 13, 2023

Indexes

Not included

Website

http://cargo-tx.com

Employees

167

Key Details

Price

$4.62(+1.54%)

Market cap

$212.76M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.72(+77.50% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.62
CRGX price is $4.62

30-Day Relative Volume

0.81
CRGX 30-day relative volume is 0.81

Price Performance

Price Today change

+1.54%
CRGX price is up +1.54% today

Price YTD change

-67.96%
CRGX price is down -67.96% since January 1st

Price 1-year change

-76.9%
CRGX price is down -76.9% year-on-year

Price 3-year change

-
CRGX price 3-year change is unknown

Price Range

Price All-time high

$33.92
CRGX price is currently -86.38% below its historical high of $33.92

Price 3-year low

$3.00
CRGX price is currently +54.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$212.76M
CRGX market capitalization is $212.76 million

Market cap 3-year change

-
CRGX market capitalization 3-year change is unknown

Market cap All-time high

$1.39B
CRGX market capitalization is currently -84.74% below its historical high of $1.39 billion

Market cap sector rank

58.39%
CRGX market capitalization is higher than 58.39% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+16.98%
CRGX shares outstanding is up +16.98% year-on-year

Shares Outstanding 3-Year Change

-
CRGX shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.91
CRGX beta is 0.91

200-day SMA

$13.85
CRGX price is currently -66.65% below its 200-day simple moving average

50-day SMA

$3.94
CRGX price is currently +17.12% above its 50-day simple moving average

RSI

56.93
CRGX 14-day relative strength index is 56.93

Volume

0.81
CRGX 30-day relative volume is 0.81

ATR

$0.28
CRGX average true range is $0.28

10-day Historical Volatility

52.81%
CRGX 10-day historical volatility is 52.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CRGX annual revenue value is unknown

Revenue Analysts estimate

-
CRGX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CRGX annual revenue 1-year change is unknown

Revenue Sector rank

-
CRGX annual revenue is unknown

EPS

EPS

-$3.72
CRGX annual earnings per share is -$3.72

EPS Analysts estimate

-$1.96
CRGX annual earnings per share is currently +89.42% higher than the consensus analysts' forecast

EPS 1-year change

+77.5%
CRGX annual earnings per share is up +77.5% year-on-year

EPS Sector rank

24.19%
CRGX annual earnings per share is higher than 24.19% of companies in Healthcare sector

Profit

Gross profit

-
CRGX annual gross profit value is unknown

Gross margin

-
CRGX annual gross profit margin value is unknown

Operating profit

-$187.37M
CRGX annual operating income is -$187.37 million

Operating margin

-
CRGX annual operating profit margin value is unknown

Net income

-$167.50M
CRGX annual net profit is -$167.50 million

Net margin

-
CRGX annual net profit margin value is unknown

Expenses

Total expenses

$187.37M
CRGX annual total expenses is $187.37 million

Operating expenses

$187.37M
CRGX annual total operating expenses is $187.37 million

Cost of goods sold

-
CRGX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$43.97M
CRGX annual SGA is $43.97 million

Depreciation and amortization

$7.07M
CRGX annual depreciation & amortization is $7.07 million

Interest expense

$0.00
CRGX annual interest expense is $0.00

Income tax

-
CRGX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$167.50M
CRGX annual earnings before interest & taxes is -$167.50 million

EBITDA

-$160.43M
CRGX annual EBITDA is -$160.43 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$414.05M
CRGX annual total assets is $414.05 million

Non current assets

$69.04M
CRGX annual long term assets is $69.04 million

Current assets

$345.01M
CRGX annual total current assets is $345.01 million

Cash and cash equivalents

$64.38M
CRGX annual cash & cash equivalents is $64.38 million

Accounts receivable

-
CRGX annual accounts receivable value is unknown

Inventory

-
CRGX annual inventory value is unknown

Liabilities

Total liabilities

$53.83M
CRGX annual total liabilities is $53.83 million

Long term liabilities

$28.80M
CRGX annual total long term liabilities is $28.80 million

Current liabilities

$25.03M
CRGX annual total current liabilities is $25.03 million

Accounts payable

$2.44M
CRGX annual accounts payable is $2.44 million

Debt

Total debt

$29.43M
CRGX annual total debt is $29.43 million

Total debt 1-year change

+3.1%
CRGX annual total debt is up +3.1% year-on-year

Long term debt

$28.80M
CRGX annual long term debt is $28.80 million

Short term debt

$628.00K
CRGX annual short term debt is $628.00 thousand

Equity & Capital

Shareholders equity

$360.23M
CRGX annual stockholders equity is $360.23 million

Book value

$360.23M
CRGX annual book value is $360.23 million

Retained earnings

-$312.65M
CRGX annual retained earnings is -$312.65 million

Working capital

$319.99M
CRGX annual working capital is $319.99 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$139.74M
CRGX annual cash flow from operations is -$139.74 million

Cash from operations 1-year change

-72.17%
CRGX annual cash flow from operations is down -72.17% year-on-year

Cash from investing

-$305.08M
CRGX annual cash flow from investing activities is -$305.08 million

Cash from investing 1-year change

-3292.78%
CRGX annual cash flow from investing activities is down -3292.78% year-on-year

Cash from financing

$103.47M
CRGX annual cash flow from financing activities is $103.47 million

Cash from financing 1-year change

-79.08%
CRGX annual cash flow from financing activities is down -79.08% year-on-year

CAPEX

CAPEX

-
CRGX annual capital expenditures value is unknown

CAPEX 1-year change

-
CRGX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$145.14M
CRGX annual free cash flow is -$145.14 million

Free cash flow 1-year change

-60.99%
CRGX annual free cash flow is down -60.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CRGX annual gross profit margin value is unknown

Operating margin

-
CRGX annual operating profit margin value is unknown

Net margin

-
CRGX annual net profit margin value is unknown

ROA & ROE

ROA

-40.45%
CRGX annual return on assets is -40.45%

ROE

-46.50%
CRGX annual return on equity is -46.50%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRGX price to earnings ratio value is unknown

PE ratio Sector rank

-
CRGX price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
CRGX price to book ratio is 0.59

PB ratio Sector rank

32.92%
CRGX price to book ratio is higher than 32.92% of companies in Healthcare sector

PS Ratio

PS ratio

-
CRGX price to sales ratio value is unknown

PS ratio Sector rank

-
CRGX price to sales ratio is unknown

Enterprise value

Enterprise value

$177.81M
CRGX enterprise value is $177.81 million

Enterprise value Sector rank

57.57%
CRGX enterprise value is higher than 57.57% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.11
CRGX EV/EBITDA is -1.11

EV/EBITDA Sector rank

40.64%
CRGX EV/EBITDA is higher than 40.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.79
CRGX annual current ratio is 13.79

Quick ratio

-
CRGX annual quick ratio value is unknown

Leverage

Debt to equity

0.08
CRGX annual debt to equity ratio is 0.08

Interest coverage ratio

-
CRGX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRGX piotroski f-score value is unknown

Altman Z-Score

-
CRGX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jan 30, 25 William Blair
Market Perform
Jan 30, 25 Truist Securities
Hold
Jan 30, 25 Piper Sandler
Neutral
Jan 30, 25 Jefferies
Hold
Jan 30, 25 JP Morgan
Underweight
Jan 30, 25 HC Wainwright & Co.
Neutral
Jan 30, 25 Chardan Capital
Neutral
Nov 26, 24 William Blair
Outperform
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

TERN logo
Terns Pharmaceuticals (TERN)
SLDB logo
Solid Biosciences (SLDB)
PDEX logo
Pro-Dex (PDEX)
QTRX logo
Quanterix (QTRX)
PLX logo
Protalix BioTherapeutics (PLX)
OCGN logo
Ocugen (OCGN)
enGene Holdings (ENGN)
AMRN logo
Amarin (AMRN)
OM logo
Outset Medical (OM)
  • What is the ticker symbol for CARGO Therapeutics?
  • Does CARGO Therapeutics pay dividends?
  • What sector is CARGO Therapeutics in?
  • What industry is CARGO Therapeutics in?
  • What country is CARGO Therapeutics based in?
  • When did CARGO Therapeutics go public?
  • Is CARGO Therapeutics in the S&P 500?
  • Is CARGO Therapeutics in the NASDAQ 100?
  • Is CARGO Therapeutics in the Dow Jones?
  • When was CARGO Therapeutics's last earnings report?
  • When does CARGO Therapeutics report earnings?
  • Should I buy CARGO Therapeutics stock now?

What is the ticker symbol for CARGO Therapeutics?

The ticker symbol for CARGO Therapeutics is NASDAQ:CRGX

Does CARGO Therapeutics pay dividends?

No, CARGO Therapeutics does not pay dividends

What sector is CARGO Therapeutics in?

CARGO Therapeutics is in the Healthcare sector

What industry is CARGO Therapeutics in?

CARGO Therapeutics is in the Biotechnology industry

What country is CARGO Therapeutics based in?

CARGO Therapeutics is headquartered in United States

When did CARGO Therapeutics go public?

CARGO Therapeutics's initial public offering (IPO) was on November 13, 2023

Is CARGO Therapeutics in the S&P 500?

No, CARGO Therapeutics is not included in the S&P 500 index

Is CARGO Therapeutics in the NASDAQ 100?

No, CARGO Therapeutics is not included in the NASDAQ 100 index

Is CARGO Therapeutics in the Dow Jones?

No, CARGO Therapeutics is not included in the Dow Jones index

When was CARGO Therapeutics's last earnings report?

CARGO Therapeutics's most recent earnings report was on Nov 12, 2024

When does CARGO Therapeutics report earnings?

The next expected earnings date for CARGO Therapeutics is May 14, 2025

Should I buy CARGO Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page